Effects of calcium dobesilate and diosmin-hesperidin on apoptosis of venous wall in primary varicose veins

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 3, 2008, Pages 233-240

  Iriz, Erkan ^a   Vural, C ^a   Ereren, E ^a   Poyraz, A ^a   Erer, D ^a   Oktar, L ^a   Gokgoz, L ^a   Valit, V ^a   Soncul, H ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Calcium dobesilate; Lipid peroxidation; Varicose veins; Venous wall

Indexed keywords

DAFLON; DOBESILATE CALCIUM; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; BAX PROTEIN, HUMAN; CARDIOVASCULAR AGENT; DIOSMIN; HESPERIDIN; TP53 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; BLOOD VESSEL BIOPSY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SAPHENOUS VEIN; VARICOSIS; VEIN WALL; AGED; CHEMISTRY; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; TREATMENT OUTCOME;

ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CALCIUM DOBESILATE; CARDIOVASCULAR AGENTS; DIOSMIN; DRUG COMBINATIONS; FEMALE; HESPERIDIN; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROTO-ONCOGENE PROTEINS C-BCL-2; SAPHENOUS VEIN; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; VARICOSE VEINS;

EID: 63049115521     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.3.233     Document Type: Article

References (40)

1. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the cell, Chapter 17; The cell cycle and Programmed cell death. Fourth edition, New York: Garland 2002: 983-1026.
2. Arnoould T, Janssens D, Michiels C, Remacle J. Effects of aescine on hypoxia-induced activation of human endothelial cells. Eur J Pharmacol 1996; 315: 227-33.
3. Ascher E, Jacob T, Hingorani A, Gunduz Y, Mazzariol F, Kallakuri S. Programmed cell death (Apoptosis) and its role in the pathogenesis of lower extremity varicose veins. Ann Vasc Surg 2000; 14: 24-30.
4. Ascher E, Jacob T, Hingorani A, Tsemekhin B, Gunduz Y. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower extremity varicose veins. J Vasc Surg 2001; 33: 1080-6.
5. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: possible explanation for extracellular matrix accumulation. J Pathol 2000; 192: 105-12.
6. Badrichani AZ, Stroka DM, Bilbao G, Curiel DT, Bach FH, Ferran C. Bcl-2 and Bcl-xl serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappa B. J Clin Invest 1999; 103: 543-53.
7. Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodeling and atherosclerotic plaque rupture. Cardiovasc Res 1999; 41: 361-8.
8. Bergan JJ, Schmid-Schonbein DW, Takase S. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg. Angiology 2001; 52: S43-S47.
9. Bradbury AW, Murie JA, Ruckley CV. Role of the leucocyte in the pathogenesis of vascular disease. Br J Surg 1993; 80: 1503-12.
10. Bruce-Keller AJ, Begley JG, Fu W, Butterfield DA, Bredesen DE, Hutchins JB, Hensley K, Mattson MP. Bcl-2 protects isolated plasma an mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J Neurochem 1998; 70: 31-9.
11. Cornu-Thernard A, Boivin P, Baud JM, De Vincenzi I, Carpentier PH. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994; 20: 318-26.
12. De-Groot H, Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 1998; 12: 249-55.
13. Ducasse E, Giannakakis K, Chevalier J, Dasnoy D, Puppinck P, Speziale F, et al. Dysregulated apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg 2005; 29: 316-23.
14. Durand E, Mallat Z, Addad F, Vilde F, Desnos M,Guerots C, et al. Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol 2002; 39: 1680-5.
15. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburg Vein Study. J Epidemiol Commun Health 1999; 53: 149-53.
16. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993; 18: 814-20.
17. Glowinski J, Glowinski S. Generation of reactive oxygen metabolites by the varicose vein wall. Eur J Vasc Endovasc Surg 2002; 23: 550-5.
18. Graber R, Farine JC, Losa AG. Calcium dobesilate protects human peripheral blood mononuclear cells from oxidation and apoptosis. Apoptosis 1998; 3: 41-9.
19. Hach-Wunderle V, Hach W. Invasive therapeutic options in truncal varicosity of the great saphenous vein. Vasa 2006; 35: 157-66.
20. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9: 691-704.
21. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implication for cardiovascular disease. Circ Res 1998; 82: 1111-29.
22. He H, Lam M, McCormick TS, Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 1997; 138: 1219-28.
23. Jiang P, van Rij AM, Christie RA, Hill GB, Thomson IA. Non-saphenofemoral venous reflux in the groin in patients with varicose veins. Eur J Vasc Endovasc Surg 2001; 21: 550-7.
24. Kirsch D, Dienes HP, Kuchle R, Duschner H, Wahl W, Bottger T, Junginger T. Changes in the extracellular matrix of the vein wall-the cause of primary varicosis? Vasa 2000; 29: 173-7.
25. Kockx MM, Knaapen MW, Bortier HE, Cromheeke KM, Boutherin-Falson O, Finet M. Vascular remodeling in varicose vein wall. Angiology 1998; 49: 871-7.
26. Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 1999; 38: 133-42.
27. Kutuk O, Basaga H. Bcl-2 protein family: Implications in vascular apoptosis and atherosclerosis. Apoptosis 2006; 11: 1661-75.
28. Little wood TD, Bennet MR. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 2003; 14: 469-75.
29. Lopez-Candel A, Holmes DR, Liao S. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysm. Am J Pathol 1997; 150: 993-1007.
30. Mayr U, Mayr M, Li C, Wernig F, Dietrich H, Hu Y, et al. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ Res 2002; 90:197-204.
31. Michal M, Giessinger N. Effect of calcium dobesilate and its interaction with aspirin on thrombus formation in vivo. Thromb Res 1985; 40: 215-26.
32. Michal M, Gotti C. Effect of calcium dobesilate on platelet function. Thromb Res 1988; 51: 593-605.
33. Sadick NS. Predisposing factors of varicose and telengiectasic leg veins. J Dermatol Surg Oncol 1992; 18: 883-6.
34. Saxena A, McMekin JD, Thomson DJ. Expression of Bcl-x, Bcl-2, and Bak in endarterectomy and atherectomy specimens. J Pathol 2002; 196: 335-42.
35. Schmekel B, Karlsson SE, Linden M, et al. Myeloperoxidase in human lung lavage.A marker of local neutrophil activity. Inflammation 1990; 14: 447-54.
36. Takase S, Pascarella L, Lerond L, Bergan JJ, Schmid-Schönbein GW. Venous hypertension, inflammation and valve remodeling. Eur J Vasc Endovasc Surg 2004; 28: 484-93.
37. Tanaka H, Okada T, Konishi H, Tsuji T. The effect of reactive oxygen species on the biosynthesis of collagen and glycosaminoglycans in cultured human dermal fibroblasts. Arch Dermatol Res 1993; 285: 352-5.
38. Urbanek T, Skop B, Wiaderkiewicz R, Wilczok T, Ziaja K, Lebda-Wyborny T, et al. Smooth muscle cell apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg 2004; 28: 600-11.
39. Urbanek T, Skop B, Ziaja K, Wilczok T, Wiaderkiewicz R, Palasz A, et al. Sapheno-femoral junction pathology: Molecular mechanism of saphenous vein incompetence. Clin Appl Thrombosis Hemostasis 2004; 10: 311-21.
40. Widmer L, Biland L, Barras JP. Doxium 500 in chronic venous insufficiency. A double blind placebo controlled multicentre study. Int Angiology 1990; 9: 105-10.